Get access to our best features
Get access to our best features
Published

Man sees deadly brain tumour shrink by half thanks to new radioactive therapy

  • A man has experienced a 50% reduction in his deadly brain tumour due to a new radioactive therapy, marking a significant development in treatment.
  • Paul Read, a 62-year-old engineer, is the first patient in this trial, witnessing a remarkable tumour size decrease in just weeks.
  • The trial aims to find effective treatments for aggressive tumours, as survival chances were initially under a year.
Insights by Ground AI
Does this summary seem wrong?
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Right
50% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)